Germany on Course for Record Number of New Approved Medications

September 2022

The Association of Researching Pharmaceutical Companies (vfa) says 36 newly approved medications have been introduced to the German market in 2022. That continues the strong innovation trend from 2021, when 46 new medicines were introduced in the calendar year, vfa added.

The new medications covered a wide range of diseases, including cancers, infections, growth disruptions, non-malign blood illnesses, joint ailments and several congenital metabolic disorders. They included two new Covid-19 vaccines and three new therapeutic medicines to combat the effects of the disease.

All of the medications listed contain new active components. Germany is Europe’s largest pharmaceuticals market and the fourth largest in the world. Turnover in 2021 was more than EUR 53 billion, representing seven percent growth year on year. Pharmaceutical companies in Germany invested 7.8 billions in R&D in 2020.

© zorazhuang/